Elizabeth Nally
London, ENG EC1M6AU, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
VEGF-TKI Outcomes in Metastatic Renal Cell Carcinoma According to Prior Immune Checkpoint Inhibitor or VEGF-TKI: A Scoping Review and Exploratory Analysis.
Journal: Cancers
Published: December 30, 2025
Established and emerging biomarkers approaches in urothelial carcinoma.
Journal: Expert review of anticancer therapy
Published: August 05, 2025
Perioperative durvalumab for muscle invasive bladder cancer: the start of a new chapter.
Journal: Future oncology (London, England)
Published: July 16, 2025
Development of a Health-related Quality of Life Questionnaire for Patients with Metastatic or Localized Renal Cell Carcinoma.
Journal: European urology oncology
Published: March 11, 2025
Landscape of subsequent therapies in perioperative immunotherapy trials across multiple cancer types.
Journal: The Lancet. Oncology
Published: August 26, 2024
Is HER2 the New NECTIN4 in Advanced Urothelial Cancer?
Journal: European urology focus
Published: March 26, 2024
NLR Outperforms Low Hemoglobin and High Platelet Count as Predictive and Prognostic Biomarker in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Journal: Clinical genitourinary cancer
Published: December 06, 2023
Upper Tract Urothelial Carcinoma (UTUC): Prevalence, Impact and Management Challenge.
Journal: Cancer management and research
Published: October 19, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026